Interim / Quarterly Report • Nov 14, 2025
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
{0}------------------------------------------------

Interim Report

January – September, 2025

{1}------------------------------------------------
times/second, all year round
Precise Biometrics (Precise) is a global pioneer in the field of cybersecurity and biometric solutions. The offering includes algorithm products for fingerprint, facial and hand recognition, as well as packaged end-customer products for biometric access (Precise Access) and visitor management (Precise Visit by EastCoast).
Our solutions offer secure and seamless access to data, mobile devices, locations and trusted identities. The focus areas are biometric authentication for mobile phones, laptops, security keys and physical access, vehicle applications for in-car payment, driver authentication and personal settings/access – as well as systems for visitor management and physical biometric access.
Interim Report January – September 2025 Precise Biometrics AB (publ), corp. ID no. 556545-6596 Precise operates through two business units, Digital Identity and Biometric Technologies, and runs the business from its offices in Lund (HQ), Stockholm, Potsdam NY, Seoul, Taipei and Shanghai. The Precise share (PREC) is listed on Nasdaq Stockholm. Find out more at www.precisebiometrics.com.
{2}------------------------------------------------
| The period in brief: Strong position and positive EBITDA | 4 |
|---|---|
| CEO comments Strong position and positive EBITDA | 6 |
| Update from the business areas | 8 |
| Customer offering | 10 |
| Net sales and operating profit/loss | 11 |
| Consolidated income statement – in summary | 16 |
| Consolidated balance sheet – in summary | 17 |
| Consolidated cash flow statement – in summary | 18 |
| Consolidated change in equity – in summary | 19 |
| Notes | 20 |
| Parent company income statement – in summary | 23 |
| Parent company balance sheet – in summary | 24 |
| Consolidated key indicators | 25 |
| Alternative consolidated key indicators | |
| Analysis of results, in summary | 27 |
| Financial glossary |
{3}------------------------------------------------
▪ Precise strengthens Precise Visit by EastCoast with new access control capabilities
{4}------------------------------------------------
| 2025 | 2024 | 2025 | 2024 | 2024 | Rolling | |
|---|---|---|---|---|---|---|
| Amounts in SEK thousands unless otherw ise stated | Jul-Sep | Jul-Sep | Jan-Sep | Jan-Sep | Full-year | 12 mth |
| Net sales | 20 006 | 22 799 | 60 797 | 65 065 | 86 852 | 82 584 |
| Net sales grow th, % | -12,3% | 28,7% | -6,6% | 18,8% | 15,7% | -3,3% |
| EBITDA | 4 351 | 6 785 | 2 115 | 9 943 | 13 379 | 5 552 |
| Gross margin, % | 75,8% | 74,3% | 73,8% | 72,7% | 72,6% | 73,4% |
| Operating profit/loss (EBIT) | -641 | 1 150 | -13 399 | -7 340 | -9 414 | -15 473 |
| Operating margin, % | -3,2% | 5,0% | -22,0% | -11,3% | -10,8% | -18,7% |
| Cash flow from the operating activities | 1 662 | 3 275 | 5 071 | 4 298 | 10 055 | 10 828 |
| Cash and cash equivalents | 31 275 | 41 650 | 31 275 | 41 650 | 37 704 | |
| Annual Recurring Revenue | 18 412 | 18 434 | 18 412 | 18 434 | 18 980 |
See the Financial Glossary for definitions.
Precise has published a video interview with CEO Joakim Nydemark in connection with this report. The interview is designed to complement the report and provide additional depth and a better understanding of the stock market for the company's business operations.
The video is available on the Investor Relations page: https://www.precisebiometrics.com/investors/
The company also invites you to a live Q&A session on November 14, 2025 at 13:00 (CET). More information and a registration link to the Q&A session may be found on the Investor Relations page:
https://www.precisebiometrics.com/investors/
Questions can be asked directly during the Q&A or submitted in advance to [email protected].
{5}------------------------------------------------
We are delivering a positive EBITDA for the quarter of SEK 4.4 million (6.8), reflecting a robust business and our ability to deliver despite a weaker US dollar and a market that remains cautious. Our recurring revenue (ARR) within Digital Identity remains stable compared to the same period last year, affected by a customer bankruptcy in the second quarter and by our migration focus to enable accelerated sustainable growth going forward. Net sales for the quarter totaled SEK 20.0 (22.8) million, and for the interim period SEK 60.8 (65.1) million. Operating expenses for the quarter are in line with the corresponding period last year.
Our position remains strong, and demand for biometric solutions is increasing, even though the market situation is affecting business in the short term. In the important mobile phone market, we not only won new projects, but also saw several launches of new models using our software. Moreover, demand for our anti-spoof solutions for national ID programs is increasing.
We have made important progress with Precise Visit by EastCoast (Precise Visit), migrating many customers to our cloud solution, creating a sustainable and scalable business over time. The technological advances we have made with synthetic biometric data are also important, as this creates both competitiveness and new business opportunities.
Demand for our products is increasing, even though the market situation is prolonging business discussions.
The shift to ultrasonic sensors in the mobile industry is progressing as expected, and future volumes look very promising. Growth is expected to continue through both higher market penetration and new segments. We are also experiencing higher levels of interest in biometric security solutions, a consequence of the rapid AI development and the changing security situation around the world.
Biometric recognition offers a unique combination of userfriendliness and security, making it an obvious choice for many users, and Precise solutions are very much leading the way. Cybersecurity is also high on the agenda of both companies and government agencies all over the world.
During the period, we integrated synthetic biometric data into our product development and also offer this as a service. This initiative sees us meeting the rapidly growing demand for high-quality biometric data, continuing to build on our expertise in data collection and anti-spoofing.
Our offering is experiencing rising demand, and we continue to win new projects together with customers and partners. There is a degree of caution in the mobile vertical, but it continues to deliver stable volumes and we see growth in the market for our product segments. Our customers are experiencing strong growth and volumes are expected to increase in the years ahead. Revenue in the automotive industry is in line with forecasts, despite the industry experiencing a generally fraught situation.
The growing market for national ID programs presents good potential, with demand for anti-spoof and liveness technology continuing to increase. We have several agreements in place with an expected roll-out during the next year.
The palm recognition initiative has also taken important steps forward in terms of both technical development and market cultivation. A pilot project is under way in the US, and our business partner HandID is preparing for mass production of its palm reader during the next few quarters, while more hardware partners are being evaluated. Furthermore, governments have started to specify strict requirements for the technology, further reinforcing its relevance.
Sales of Precise Visit continue at a healthy pace, with an increased inflow of new customers and recurring revenue. Since last summer, we have put extra effort into migrating customers from the company's on-premise solution to the new generation cloud-based solution. This is affecting growth in the short term, but will bring scalability, costefficiency and loyalty in the longer term.
The benefits of our cloud-based solution include physical access functionality and integrations with many of the leading access systems, opening up an extended offering to existing customers – as well as the possibility of totally hardware-free visitor management in which visitors check in using their own device.
{6}------------------------------------------------
Our new partnership with Avigilon is also a major event, which sees us integrating Precise Access with their physical access control system. The solution is being sold via Avigilon's global partner network and includes two-factor authentication for enhanced security.
We continue to invest in expanding our market presence and driving sales, including active customer engagement in new markets. Framework agreements with major companies are also expected to support positive growth ahead.
Market cultivation continues, and during the quarter we further boosted our digital presence with segmented campaigns aimed at relevant target groups, which have generated results in the form of incoming inquiries.
Notable activities include website optimization, activities in Norway, the migration of Precise Visit customers, the GSX security trade show in the US together with Avigilon, and campaigns linked to national ID programs. I also took part in activities including Redeye Cybersecurity Day and the Rapidus podcast Lejonkulan.
I have a very positive view of the future. In a society where security and user-friendliness are becoming increasingly central, our solutions help create greater peace of mind. Biometrics, cybersecurity and artificial intelligence are the foundation of our business.
As one of a small number of actors in the field of ultrasonic algorithms, I see potential for increased revenue, while we make progress in the areas of cybersecurity, biometric solutions for government agency projects and visitor management systems. Moreover, by optimizing our supplier agreements and improving efficiency, we have succeeded in increasing sales capacity and productivity without a significant increase in costs. I believe this will have a positive effect on earnings going forward.
A strong product portfolio, stable finances and long-term partnerships put us in a healthy position, and I look forward with confidence to continuing our journey.
Joakim Nydemark
CEO

{7}------------------------------------------------
Biometric Technologies has experienced a quarter of continued positive growth and a high tempo in both existing projects and new business discussions. Unfortunately, the global situation is affecting sales of many of the company's customers, primarily in the mobile industry, which means lower volumes for the quarter compared with the corresponding period last year. The US dollar rate also continues to have a negative impact. At the positive end of the scale, demand remains strong for BioLive and solutions for ultrasonic sensors, and during the period the company not only won new projects, but also saw new mobile phones containing BioMatch and BioLive reach the market.
lead time from certification and implementation to revenue is longer than in other projects.

{8}------------------------------------------------
The quarter was characterized by a high level of activity in the market and numerous sales meetings. The focus for Precise Access was on the US and getting the new partner Avigilon up and running. For Precise Visit by EastCoast, the focus was on new sales in Sweden and Norway, and on migrating on-premise customers to the cloud.
The ARR stock has been stable in recent months, despite healthy new sales. The reason is the migration focus, and that some older Precise Visit on-premise customers, who previously paid for the product but did not actively use it, have chosen to terminate their agreements in connection with a campaign to encourage migration to the cloud. This churn is of a non-recurring nature and is expected to have a much smaller impact going forward. It has had a negative impact on the ARR stock in the short term, but is in line with the strategic choice to build a scalable cloud solution instead of further developing the older on-premise product. The cloud brings many benefits – more functionality, simpler upgrades and reduced support requirements – which combine to boost the profitability and scalability of the business. The cloud solution is growing steadily, and the management team at Precise is confident that this is the right way to drive long-term, scalable growth.
The two products have undergone a process of rebranding to Precise Visit by EastCoast and Precise Access. To achieve efficiency and minimal customer impact, the project is being implemented as an ongoing project that is expected to be completed during the first half of 2026.
There has been a healthy inflow of new customers, with several new agreements in both private and public sectors. Migration to the cloud platform has also seen a positive trend with customers such as Copenhagen Malmö Port, IF Skadeförsäkringar and Sweco – all with strict requirements for security and scalability.
Several new functions were launched during the period, while improvements were made in security, integrations and user-friendliness. Examples of new features include event visits and packaged access integrations in Precise Visit, as well as packaged integration to palm and integration to Avigilon in Precise Access. Rebranding to Precise Access and Precise Visit by EastCoast is also part of the roadmap.

{9}------------------------------------------------
In a world where security, user-friendliness and AI are key, Precise offers biometric security and access management solutions that provide secure and convenient access to data, mobile devices, locations and trusted identities.
Simplicity and a first-class user experience are combined with high levels of performance and security. Instead of using a PIN, password, key or card, you use your finger, face or hand for authentication or identification – quickly, securely and conveniently.
Our offering in the areas of physical access, visitor management and biometric recognition makes everyday life safe and seamless.
Areas of applications cover both digital and physical access – from mobile phones, laptops and logical access to payment, vehicles, visitor and access management systems, as well as government agency initiatives such as national ID programs and Automated Biometric Identification Systems (ABIS).
100% software and SaaS, providing flexibility and the facility to make quick changes.
Hardware-independent our solutions work with multiple sensor types and platforms.

{10}------------------------------------------------
Net sales during the quarter totaled SEK 20.0 (22.8) million, divided between royalty revenues of SEK 9.3 (11.0) million, license fees (including support and maintenance) of SEK 9.7 (11.0) million and other revenues of SEK 1.0 (0.8) million. Royalty revenues during the quarter were affected by slightly lower volumes from our customers, reflecting variations in the production of mobile devices. A weaker USD also contributed to lower revenue during the period.
Net sales for Biometric Technologies totaled SEK 14.9 (17.5) million and are reported under royalties at SEK 9.3 (11.0) million, licenses at SEK 5.2 (6.4) million, and other revenue at SEK 0.5 (0.1) million. Royalty revenues were slightly lower during the quarter, due to lower customer volumes and a weaker USD. As the biometric algorithm business is affected by customers' production levels, which may vary between quarters, the trend should be assessed over time rather than on the basis of individual quarters. The gross margin during the quarter totaled 84.6% (82.0). The improvement in the gross margin is explained by reduced amortization of previously capitalized development expenses and lower costs of goods.
Net sales for Digital Identity totaled SEK 5.1 (5.3) million and are reported under licenses at SEK 4.6 (4.6) million, and other revenues at SEK 0.5 (0.7) million.
The proportion of annual recurring revenue (ARR) was SEK 18.4 (18.4) million at the end of the quarter. One consequence of the company's strategy to increase the proportion of recurring revenue (ARR) and gradually replace older products is that there has been some churn.
The comparison is still affected by one customer agreement that was terminated in the previous quarter. The ARR level is otherwise stable, with positive new sales.
The gross margin during the quarter totaled 50.0% (49.0). The improved gross margin is due to reduced depreciation/ amortization, which in turn is an effect of lower capitalization of development expenses in previous periods.
The gross margin during the quarter totaled 75.8% (74.3). The increase is due to both reduced depreciation/amortization and lower cost of goods during the quarter. Amortization of capitalized development expenses totaled SEK 3.5 (4.1) million. Amortization of acquired intangible assets totaled SEK 0.6 (0.6) million.
Operating expenses during the quarter totaled SEK 15.8 (15.8) million, which is on par with the same period in the previous year.
The profit/loss at EBITDA level totaled SEK 4.4 (6.8) million, which is primarily due to lower net sales and the exchange rate impact on revenue.
The operating profit/loss (EBIT) for the quarter totaled SEK -0.6 (1.2) million. Earnings for the quarter totaled SEK -0.7 (1.4) million. Total depreciation/amortization was SEK 5.0 (5.6) million.
Earnings per share (average number of shares) for the quarter totaled SEK -0.01 (0.02).


{11}------------------------------------------------
Net sales during the interim period totaled SEK 60.8 (65.1) million. Net sales were reported under royalty revenues at SEK 26.8 (29.6) million, license fees (including support and maintenance) at SEK 29.5 (31.2) million and other revenue at SEK 4.5 (4.3) million. Royalty revenues decreased as a consequence of a renegotiated customer agreement, which entails increased revenue on an annual basis but lower revenue during the interim period by approximately SEK 1.8 million. License fees were down primarily due to changes in the composition of customers and the reduced support needs of some customers. A weaker USD also had a negative impact on revenue.
Net sales for Biometric Technologies totaled SEK 45.2 (49.2) million and are reported under royalties at SEK 26.8 (29.6) million, licenses at SEK 15.7 (17.3) million, and other revenue at SEK 2.7 (2.3) million. Royalty revenues during the interim period were slightly lower than in the previous year, affected by a renegotiated customer agreement and a weaker USD. License fees were down year-on-year mainly as a consequence of changes in the composition of customers and renegotiated license agreements linked to the reduced support needs of some customers. The gross margin during the interim period was 83.2% (83.9).
Net sales for Digital Identity totaled SEK 15.6 (15.9) million and are reported under licenses at SEK 13.8 (13.8) million, and other revenue at SEK 1.8 (2.0) million. The ARR at the end of the interim period was SEK 18.4 (18.4) million. One consequence of the company's strategy to increase the proportion of annual recurring revenue (ARR) and gradually migrate older products, some churn also occurred during the interim period. The impact of a customer agreement that was terminated during the first half of the year still affects the comparison. The ARR level remains largely unchanged compared with the previous year, while there was a positive trend in new sales. The gross margin during the interim period was 46.4% (37.9).
The gross margin during the interim period was 73.8% (72.7). The improved gross margin is due to reduced depreciation/amortization, which in turn is an effect of lower capitalization of development expenses in previous periods. Total amortization of capitalized development expenses was SEK 11.0 (12.5) million. Amortization of acquired intangible assets totaled SEK 1.8 (1.8) million.
Operating expenses for the interim period increased to SEK 58.2 (54.6) million. During the interim period, the company was negatively affected by the trend in the USD exchange rate, which in its entirety resulted in other operating expenses of SEK -2.5 million. The corresponding interim period in the previous year saw operating income of SEK 0.3 million, which means a currency-related change of SEK 2.8 million between the periods.
The profit/loss at EBITDA level fell to SEK 2.1 (9.9) million. This decrease is explained by lower net sales due to a weaker USD and higher operating costs, mainly attributable to exchange rate differences. A renegotiated customer agreement also affected earnings, with revenue that was approximately SEK 1.8 million lower in the quarter, but higher revenue on an annual basis.
The operating profit/loss for the interim period totaled SEK - 13.4 (-7.3) million. Earnings for the interim period totaled SEK - 13.6 (-7.1) million. Total depreciation/amortization totaled SEK 15.5 (17.3) million. Earnings per share (average number of shares) for the interim period totaled SEK -0.17 (-0.09).
Net financial items for the quarter totaled SEK -0.1 (0.2) million and the tax expense totaled SEK 0.1 (0.1) million. Net financial items for the interim period totaled SEK -0.5 (-0.1) million and the tax expense totaled SEK 0.3 (0.3) million.
Net financial items are attributable to exchange rate differences in cash and cash equivalents, interest income, interest on the lease liability in accordance with IFRS 16, as well as interest expense on the deferred fixed purchase price related to the acquisition of EastCoast.
The cash flow from operating activities during the quarter totaled SEK 1.7 (3.3) million, of which SEK -2.5 (-3.6) million is attributable to changes in working capital. The Group invested SEK 0.4 (0.3) million in property, plant and equipment during the quarter. Total cash flow for the quarter was SEK -2.3 (0.0) million.
Cash flow for the interim period from operating activities totaled SEK 5.1 (4.3) million, primarily attributable to a positive change in working capital of SEK 3.6 (-5.6) million. The Group invested SEK 1.1 (0.2) million in property, plant and equipment during the interim period. Total cash flow for the interim period was SEK -6.1 (-5.9) million.
{12}------------------------------------------------
Development expenses of SEK 3.0 (2.5) million were capitalized during the quarter, and amortization of capitalized development expenses in respect of Digital Identity and Biometric Technologies totaled SEK 3.5 (4.1) million. Development expenses of SEK 8.8 (8.1) million were capitalized during the interim period, and amortization of capitalized development expenses totaled SEK 11.0 (12.5) million.
No new rental agreements were added during the quarter, but the interim period saw an extension of rental agreements in Lund and indexation of rent in Lund and Stockholm, which resulted in an increase in lease liabilities of SEK 3.4 (5.8) million. Right of use assets totaled SEK 10.7 (7.9) million at the end of the period.
Cash and cash equivalents at the end of the period totaled SEK 31.3 (41.7) million. Total equity at the end of the period was SEK 137.4 (152.2) million, and equity per share was SEK 1.75 (1.94).

The parent company's net sales for the quarter totaled SEK 16.2 (19.0) million and the operating profit/loss for the quarter totaled SEK-1.0 (-0.3) million and was charged with amortization of goodwill totaling SEK 0.6 (0.6) million. Net sales for the interim period totaled SEK 48.1 (52.2) million. The operating profit/loss totaled SEK -13.7 (-8.6) million and was charged with amortization of goodwill totaling SEK 1.8 (1.8) million. Cash and cash equivalents at the end of the interim period totaled SEK 23.4 (29.2) million, and equity SEK 125.1 (140.8) million.
The organization consists of the head office in Lund, Sweden, and offices in Stockholm, Sweden, Potsdam, USA, and Shanghai, China. At the end of the interim period, the Group had a workforce of 46 (40) people, including on-site consultants. The number of employees was 37 (30), of which 30 (23) were located in Sweden. Precise works in an agile way together with several partners, creating a fast-moving, scalable organization. The number of employees does not include partners.
The Group and parent company's business risks and risk management as well as the management of financial risks are described in detail in the Annual Report for 2024, which was issued in April 2025. There have been no incidents of significant importance since then that would affect or change these descriptions of the Group or parent company's risks and how they are managed.
Precise Biometrics AB (publ), corporate ID number 556545- 6596, is the parent company in the Precise Biometrics Group. Precise Biometrics AB's shares are listed on the Nasdaq OMX Nordic Small Cap list. The number of shareholders at the end of the quarter was 20,261 (22,369). 13,668,521 (154,050,244) PREC shares were traded during the quarter. The closing price on September 30 was SEK 3.20 (3.68), and during the quarter the share price fluctuated between SEK 2.57 (3.22) and SEK 3.63 (8.80).
{13}------------------------------------------------
This interim report has been the subject of a summary audit by the company's auditors.
The undersigned certify that the interim report provides a true and fair view of the parent company and Group's operations, financial position and financial results, and describes the significant risks and uncertainty factors faced by the parent company and the companies that belong to the Group.
Lund, November 14, 2025
Chairman of the Board
| Howard Ro | Peter Gullander | Victor Kuzmin | Maria Rydén | Åsa Schwarz |
|---|---|---|---|---|
| Board member | Board member | Board member | Board member | Board member |
Joakim Nydemark
CEO
For further information, please contact:
Joakim Nydemark, CEO
Email: joakim.ný[email protected]
This information is information that Precise Biometrics AB is obligated to disclose pursuant to the EU Market Abuse Regulation. The information was submitted for publication on November 14, 2025 at 08:00 (CET).
{14}------------------------------------------------
This is a translation from the Swedish original
Precise Biometrics AB (publ), corporate identity number 556545-6596
To the Board of Directors of Precise Biometrics AB (publ)
We have reviewed the condensed interim report for Precise Biometrics AB (publ) as at September 30, 2025 and for the nine months period then ended. The Board of Directors and the Managing Director are responsible for the preparation and presentation of this interim report in accordance with IAS 34 and the Swedish Annual Accounts Act. Our responsibility is to express a conclusion on this interim report based on our review.
We conducted our review in accordance with the International Standard on Review Engagements, ISRE 2410 Review of Interim Financial Statements Performed by the Independent Auditor of the Entity. A review consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing and other generally accepted auditing standards in Sweden. The procedures performed in a review do not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Based on our review, nothing has come to our attention that causes us to believe that the interim report is not prepared, in all material respects, in accordance with IAS 34 and the Swedish Annual Accounts Act regarding the Group, and in accordance with the Swedish Annual Accounts Act regarding the Parent Company.
Malmö, November 14, 2025
Ernst & Young AB
Martin Henriksson
Authorized Public Accountant
{15}------------------------------------------------
| 2025 | 2024 | 2025 | 2024 | 2024 | Rolling | ||
|---|---|---|---|---|---|---|---|
| Amounts in SEK thousand | Note | Jul-Sep | Jul-Sep | Jan-Sep | Jan-Sep | Full-year | 12 mth |
| Net sales | 2,3 | 20 006 | 22 799 | 60 797 | 65 065 | 86 852 | 82 584 |
| Cost of goods sold | -4 838 | -5 863 | -15 958 | -17 771 | -23 786 | -21 973 | |
| Gross profit | 15 168 | 16 936 | 44 839 | 47 294 | 63 066 | 60 611 | |
| Marketing and sales expenses | -6 855 | -6 705 | -24 761 | -24 588 | -32 982 | -33 155 | |
| Administrative expenses | -2 881 | -2 495 | -10 711 | -10 089 | -13 789 | -14 411 | |
| R&D expenses | -6 033 | -6 325 | -20 279 | -20 219 | -26 966 | -27 026 | |
| Other operating income/expenses | -40 | -260 | -2 487 | 263 | 1 256 | -1 494 | |
| -15 809 | -15 786 | -58 238 | -54 634 | -72 480 | -76 086 | ||
| Operating profit/loss | -641 | 1 150 | -13 399 | -7 340 | -9 414 | -15 473 | |
| Finacial income/expenses | 4 | -100 | 159 | -479 | -60 | 630 | 211 |
| Profit/Loss before tax | -741 | 1 309 | -13 878 | -7 400 | -8 784 | -15 262 | |
| Tax | 87 | 88 | 260 | 262 | 351 | 349 | |
| Profit/loss for the period attributable to parent company shareholders |
-654 | 1 396 | -13 618 | -7 138 | -8 433 | -14 913 | |
| Earnings per share, remaining operations, SEK* | |||||||
| - before dilution | -0,01 | 0,02 | -0,17 | -0,09 | -0,11 | -0,19 | |
| - after dilution | -0,01 | 0,02 | -0,17 | -0,09 | -0,11 | -0,19 | |
| CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME | |||||||
| Profit/Loss for the period | -654 | 1 396 | -13 618 | -7 138 | -8 433 | -14 913 | |
| Other comprehensive income: | |||||||
| Items that may be reclassified to profit or loss | |||||||
| Changes in accumulated exchange rate differences | -19 | -125 | -558 | 16 | 274 | -300 | |
| Other comprehensive income for the period | -19 | -125 | -558 | 16 | 274 | -300 | |
| Profit/Loss total attributable to holders of participations | |||||||
| in the parent company | -673 | 1 271 | -14 176 | -7 122 | -8 159 | -15 213 |
*Dilution effects are only considered in the event that the earnings per share become worse. Dilution effects have not been considered, as the average price is below the subscription price in current option programs.
{16}------------------------------------------------
Amounts in SEK thousand
| ASSETS | Note | 2025-09-30 2024-09-30 2024-12-31 | ||
|---|---|---|---|---|
| FIXED ASSETS | ||||
| Material assets | 12 410 | 9 645 | 10 639 | |
| Goodw ill and immaterial assets | 120 665 | 126 408 | 124 741 | |
| TOTAL FIXED ASSETS | 133 075 | 136 053 | 135 380 | |
| CURRENT ASSETS | ||||
| Inventories | 250 | 231 | 242 | |
| Accounts receivable | 13 023 | 15 836 | 23 813 | |
| Other current receivabels | 4 025 | 4 388 | 3 123 | |
| Accruals and deferred income | 2 561 | 2 710 | 2 804 | |
| Cash and cash equivalents | 4,6 | 31 275 | 41 650 | 37 704 |
| TOTAL CURRENT ASSETS | 51 134 | 64 815 | 67 686 | |
| TOTAL ASSETS | 184 209 | 200 868 | 203 066 | |
| EQUITY AND LIABILITIES | ||||
| EQUITY | ||||
| Equity | 137 395 | 152 200 | 151 163 | |
| TOTAL EQUITY ATTRIBUTABLE TO PARENT COMPANY SHAREHOLDERS | 137 395 | 152 200 | 151 163 | |
| LONG-TERM DEBT | ||||
| Long term debt | 6 | 18 007 | 21 150 | 16 281 |
| TOTAL LONG-TERM DEBT | 18 007 | 21 150 | 16 281 | |
| SHORT-TERM LIABILITIES | ||||
| Short-term liabilities | 4,6 | 28 807 | 27 518 | 35 621 |
| Total Short-term liabilities | 28 807 | 27 518 | 35 621 | |
| TOTAL EQUITY AND LIABILITIES | 184 209 | 200 868 | 203 066 |
{17}------------------------------------------------
| 2025 | 2024 | 2025 | 2024 | 2024 | Rolling | ||
|---|---|---|---|---|---|---|---|
| Amounts in SEK thousand | Note | Jul-Sep | Jul-Sep | Jan-Sep | Jan-Sep | Full-year | 12 mth |
| Cash flow from operating activities | |||||||
| Operating profit/loss | -641 | 1 150 | -13 399 | -7 340 | -9 414 | -15 473 | |
| Adjustments for items not included in cash flow | 4 938 | 5 519 | 15 347 | 17 267 | 22 928 | 21 008 | |
| Interest payments, net | -101 | 159 | -479 | -60 | 630 | 211 | |
| Tax paid | 4 | - 2 | 4 | -13 | -22 | - 6 | |
| Cash flow from operating activities | 4 199 | 6 826 | 1 472 | 9 854 | 14 122 | 5 740 | |
| before changes in working capital | |||||||
| Cash flow from changes in working capital | |||||||
| Change in inventories | -25 | 60 | - 8 | 128 | 117 | -19 | |
| Change in current receivables | 2 260 | 3 609 | 10 087 | 2 668 | -4 113 | 3 306 | |
| Change in current liabilities | -4 772 | -7 221 | -6 480 | -8 352 | -71 | 1 801 | |
| -2 537 | -3 552 | 3 599 | -5 556 | -4 067 | 5 088 | ||
| Cash flow from operating activities | 1 662 | 3 275 | 5 071 | 4 298 | 10 055 | 10 828 | |
| Acquisition of subsidiaries | 6 | 0 | 0 | 0 | 0 | -6 168 | -6 168 |
| Investment in fixed assets | -380 | -343 | -1 092 | -236 | -370 | -1 226 | |
| Investment in intangible assets | -3 035 | -2 327 | -8 757 | -8 056 | -10 967 | -11 668 | |
| Cash flow from investing activities | -3 415 | -2 670 | -9 849 | -8 292 | -17 505 | -19 062 | |
| Repurchase of ow n shares | 0 | 0 | 0 | - 2 | - 3 | - 1 | |
| Payment for sale/buy-back of options | 0 | 0 | 407 | 0 | 0 | 407 | |
| Payment of lease liability | -572 | -641 | -1 765 | -1 901 | -2 542 | -2 406 | |
| Cash flow from financing activities | -572 | -641 | -1 358 | -1 903 | -2 545 | -2 000 | |
| Total Cash flow | -2 325 | -36 | -6 136 | -5 897 | -9 994 | -10 233 | |
| Cash & cash equivalents at beginning of year | 33 577 | 41 746 | 37 704 | 47 534 | 47 534 | 41 650 | |
| Exchange rate differences in cash & cash equivalents | 24 | -60 | -294 | 13 | 164 | -143 | |
| Cash & cash equivalents at end of period 1) | 31 275 | 41 650 | 31 275 | 41 650 | 37 704 | 31 275 |
1) The balance sheet item Cash & Cash Equivalents only includes bank balances at both the beginning and end of the period.
{18}------------------------------------------------
| Amounts in SEK thousand | 2025 | 2024 | 2024 | Rolling | |
|---|---|---|---|---|---|
| Note | Jul-Sep | Jul-Sep | Full-year | 12 mth | |
| Equity at start of period | 151 163 | 159 319 | 159 319 | 152 200 | |
| Comprehensive income | |||||
| Profit/loss for the period | -13 618 | -7 138 | -8 433 | -14 913 | |
| Other comprehensive income | |||||
| Exchange differences | -558 | 16 | 274 | -300 | |
| Total other comprehensive income | -558 | 16 | 274 | -300 | |
| Total comprehensive income | -14 176 | -7 122 | -8 159 | -15 213 | |
| Transactions with shareholders | |||||
| LTI programme | 5 | 409 | 2 | 2 | 409 |
| Total transactions w ith shareholders | 409 | 2 | 2 | 409 | |
| Equity end of period | 137 395 | 152 200 | 151 163 | 137 395 |
{19}------------------------------------------------
This interim report has been prepared in accordance with IAS 34 Interim Financial Reporting. The parent company's financial statements have been prepared in accordance with the Swedish Annual Accounts Act and the Swedish Annual Reporting Board's recommendation RFR 2, Accounting for Legal Entities. The recognition and measurement policies and bases of estimates applied in the Annual Report for 2024 report have also been used in this interim report.
| 2025 | 2024 | 2025 | 2024 | 2024 | Rolling | |
|---|---|---|---|---|---|---|
| Amounts in SEK thousand | Jul-Sep | Jul-Sep | Jan-Sep | Jan-Sep | Full-year | 12 mth |
| Segment | ||||||
| Biometric Technologies | ||||||
| Royalty | 9 300 | 10 998 | 26 767 | 29 583 | 41 089 | 38 274 |
| Licenses, incl. support & maintenance | 5 162 | 6 352 | 15 651 | 17 347 | 21 976 | 20 280 |
| Other | 477 | 114 | 2 750 | 2 284 | 2 358 | 2 824 |
| Digital Identity | ||||||
| Licenses, incl. support & maintenance | 4 574 | 4 607 | 13 835 | 13 804 | 18 588 | 18 618 |
| Other | 493 | 728 | 1 795 | 2 048 | 2 841 | 2 587 |
| Total | 20 006 | 22 799 | 60 797 | 65 065 | 86 852 | 82 584 |
| Timing of revenue recognition | ||||||
| At point in time* | 10 296 | 13 599 | 31 241 | 35 361 | 47 777 | 43 656 |
| Over time** | 9 710 | 9 200 | 29 556 | 29 704 | 39 075 | 38 927 |
| Total | 20 006 | 22 799 | 60 797 | 65 065 | 86 852 | 82 584 |
| Region/Country | ||||||
| Europe | 6 134 | 7 985 | 19 020 | 20 927 | 27 598 | 25 691 |
| - w hereof Sw eden | 4 735 | 4 884 | 14 732 | 15 199 | 20 356 | 19 888 |
| Asia | 6 845 | 6 273 | 20 481 | 22 192 | 29 443 | 27 732 |
| - w hereof China | 246 | 342 | 796 | 1 040 | 1 372 | 1 129 |
| - w hereof Taiw an | 5 513 | 5 247 | 16 827 | 18 838 | 24 963 | 22 953 |
| USA | 7 027 | 8 541 | 21 296 | 21 946 | 29 811 | 29 161 |
| Total | 20 006 | 22 799 | 60 797 | 65 065 | 86 852 | 82 584 |
* Sale at a certain time means that revenue is reported point-in-time at the start of the agreement period, when control has been transferred to the customer.
** Sales over time means that revenue is accrued on a straight-line basis over the term of the agreement.
{20}------------------------------------------------
| 2025 | 2024 | |||||
|---|---|---|---|---|---|---|
| Jul-Sep | Jul-Sep | |||||
| Biometric Technologies |
Digital Identity |
Total Segment |
Biometric Technologies |
Digital Identity |
Total Segment |
|
| Net sales | 14 939 | 5 068 | 20 006 | 17 465 | 5 334 | 22 799 |
| Cost of goods sold exkl. depreciation | -77 | -865 | -942 | -510 | -855 | -1 365 |
| Depreciation included in cost of sold goods | -2 229 | -1 667 | -3 896 | -2 633 | -1 865 | -4 498 |
| Gross profit | 12 633 | 2 536 | 15 168 | 14 322 | 2 614 | 16 936 |
| 2025 | 2024 | |||||
| Jan-Sep | Jan-Sep | |||||
| Biometric | Digital | Total | Biometric | Digital | Total | |
| Technologies | Identity | Segment | Technologies | Identity | Segment | |
| Net sales | 45 167 | 15 630 | 60 797 | 49 214 | 15 851 | 65 065 |
| Cost of goods sold exkl. depreciation | -800 | -2 875 | -3 674 | -834 | -3 094 | -3 928 |
| Depreciation included in cost of sold goods | -6 787 | -5 496 | -12 283 | -7 089 | -6 754 | -13 843 |
| Gross profit | 37 580 | 7 259 | 44 839 | 41 291 | 6 003 | 47 294 |
| 2024 | Rolling | |||||
| Full-year | 12 mth | |||||
| Biometric | Digital | Total | Biometric | Digital | Total | |
| Technologies | Identity | Segment | Technologies | Identity | Segment | |
| Net sales | 65 424 | 21 428 | 86 852 | 61 377 | 21 206 | 82 584 |
| Cost of goods sold exkl. depreciation | -1 259 | -4 297 | -5 556 | -1 225 | -4 078 | -5 302 |
| Depreciation included in cost of sold goods | -9 402 | -8 828 | -18 230 | -9 100 | -7 570 | -16 670 |
| Gross profit | 54 764 | 8 303 | 63 066 | 51 053 | 9 558 | 60 611 |
Only net sales and product costs are allocated to each segment. Other costs are not allocated at segment level as these items relate to group operations
| 2025 | 2024 | 2025 | 2024 | 2024 | Rolling | |
|---|---|---|---|---|---|---|
| Reconciliation profit/Loss | Jul-Sep | Jul-Sep | Jan-Sep | Jan-Sep | Full-year | 12 mth |
| Gross profit | 15 168 | 16 936 | 44 839 | 47 294 | 63 066 | 60 611 |
| Marketing and sales expenses | -6 855 | -6 705 | -24 761 | -24 588 | -32 982 | -33 155 |
| Administrative expenses | -2 881 | -2 495 | -10 711 | -10 089 | -13 789 | -14 411 |
| R&D expenses | -6 033 | -6 325 | -20 279 | -20 219 | -26 966 | -27 026 |
| Other operating income/expenses | -40 | -260 | -2 487 | 263 | 1 256 | -1 494 |
| Finacial income/expenses | -100 | 159 | -479 | -60 | 630 | 211 |
| Profit/Loss before tax | -741 | 1 309 | -13 878 | -7 400 | -8 784 | -15 262 |
{21}------------------------------------------------
The fair value in respect of financial assets and liabilities corresponds in all material respects with the carrying amount in the balance sheet.
On November 30, 2022, a supplementary agreement was signed that changed the terms and conditions for the remaining liability of SEK 55,000 thousand for the acquisition of EastCoast Solutions AB (see Note 6). SEK 30,000 thousand was paid on December 1, 2022, SEK 10,000 thousand on November 30, 2023 and SEK 5,000 thousand on November 30, 2024. SEK 5,000 thousand will be paid on November 30, 2025 and SEK 5,000 thousand on November 30, 2026. Interest will be added to the amounts of SEK 5,000 thousand due on November 30, 2025 and SEK 5,000 thousand due on November 30, 2026. Interest for the period from December 1, 2023 to November 30, 2024 was paid on November 30, 2024. The interest, of 3 months STIBOR + 8%, will be added from November 30, 2023 until the amounts have been paid. The liability is recognized as an interest-bearing liability as of September 30, 2025.
The liability has been calculated at current value at the original effective interest rate of 1.8% and is recognized as other current liabilities (SEK 5,987 thousand) and other non-current liabilities (SEK 5,386 thousand).
The Annual General Meeting 2022 resolved, in accordance with the Board's proposal, to establish a long-term share bonus program (LTI 2022/2028) for all employees at Precise Biometrics. In order to facilitate the implementation of LTI 2022/2028 and to ensure the delivery of shares to the participants, and to cover the company's costs for social security contributions, the meeting also decided to amend the Articles of Association in the form of the introduction of new Class C shares, authorization for the Board of Directors to issue Class C shares, authorization for the Board of Directors to buy back Class C shares, and approval of the transfer of shares to participants in LTI 2022/2028. The implementation of Class C shares took place in Q4 2022. As of June 30, 2025, Precise Biometrics held 1,085,000 Class C shares.
The Annual General Meeting 2025 resolved, in accordance with the Board's proposal, to establish a new long-term incentive plan (LTIP 2025/2028) for senior executives and other current and future employees within the Group by issuing a maximum of 1,200,000 stock options, which means that the company's share capital may increase by a maximum of SEK 360,000. All stock options have been issued free of charge to the wholly-owned subsidiary, Precise Biometrics Services AB, for onward transfer at market value to current employees who have been offered the opportunity to participate and to future employees within the Group.
As of June 30, 2025, approximately 450,000 stock options had been transferred to participants. The stock options have a term of three years and can be exercised for the subscription of shares during the period from August 1, 2028 to September 30, 2028. The conditions for continued holding and the right to exercise the options are regulated in separate transfer agreements, and may be affected by, for example, the termination of employment. Each stock option entitles the holder to subscribe to one new share in the company at a redemption price of SEK 5.63 per share. As the options have been acquired at market value, there is no accounting cost for the company in accordance with IFRS 2.
As of November 30, 2021, the Group acquired 100% of the shares in EastCoast Solutions AB and Besökssystem Sverige AB.
The purchase price totaled SEK 86,203 thousand, of which SEK 24,466 thousand was paid as of December 31, 2021, partly via a cash payment of SEK 18,000 thousand and partly via the issuing of new shares totaling SEK 6,466 thousand. An additional SEK 8,268 thousand was paid in cash in January 2022.
On November 30, 2022, a supplementary agreement was signed that changed the terms and conditions for the remaining liability of SEK 55,000 thousand for the acquisition. See Note 4 for details of the new terms and conditions.
During the interim period of 2025, there is no impact on the Group's cash and cash equivalents in respect of business combinations.
{22}------------------------------------------------
| 2025 | 2024 | 2025 | 2024 | 2024 | Rolling | ||
|---|---|---|---|---|---|---|---|
| Amounts in SEK thousand | Note | Jul-Sep | Jul-Sep | Jan-Sep | Jan-Sep | Full-year | 12 mth |
| Net sales | 1 | 16 234 | 18 994 | 48 140 | 52 202 | 69 959 | 65 897 |
| Cost of goods sold | -6 687 | -8 229 | -21 351 | -23 555 | -32 412 | -30 208 | |
| Gross profit | 9 546 | 10 765 | 26 789 | 28 647 | 37 547 | 35 689 | |
| Marketing and sales expenses | -4 189 | -4 120 | -15 279 | -15 429 | -20 783 | -20 633 | |
| Administrative expenses | -2 758 | -2 386 | -10 313 | -9 671 | -13 227 | -13 869 | |
| R&D expenses | -3 559 | -4 140 | -12 447 | -12 434 | -16 031 | -16 044 | |
| Other operating income/expenses | -41 | -400 | -2 479 | 267 | 1 261 | -1 485 | |
| -10 547 | -11 046 | -40 517 | -37 267 | -48 780 | -52 030 | ||
| Operating profit/loss | -1 000 | -281 | -13 728 | -8 620 | -11 233 | -16 341 | |
| Financial income/expenses | -27 | 197 | -189 | 152 | 809 | 468 | |
| Group contributions received | 0 | 0 | 0 | 0 | 151 | 151 | |
| Profit/loss before tax | -1 028 | -84 | -13 917 | -8 468 | -10 274 | -15 723 | |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit/loss for the period | -1 028 | -84 | -13 917 | -8 468 | -10 274 | -15 723 |
{23}------------------------------------------------
| ASSETS Note |
2025-09-30 | 2024-09-30 | 2024-12-31 |
|---|---|---|---|
| Fixed assets | |||
| Fixed assets | 1 287 | 1 344 | 1 196 |
| Immaterial assets | 18 971 | 24 579 | 22 812 |
| Deferred tax assets | 90 558 | 90 558 | 90 558 |
| TOTAL FIXED ASSETS | 110 816 | 116 481 | 114 566 |
| CURRENT ASSETS | |||
| Accounts receivable | 10 719 | 13 713 | 20 859 |
| Receivable Group | 6 068 | 10 689 | 8 145 |
| Other receivables | 2 260 | 2 623 | 1 841 |
| Accruals and deferred income | 2 070 | 2 236 | 2 449 |
| Cash and cash equivalents | 23 421 | 29 240 | 25 452 |
| TOTAL CURRENT ASSETS | 44 539 | 58 501 | 58 746 |
| TOTAL ASSETS | 155 355 | 174 982 | 173 312 |
| EQUITY AND LIABILITIES | |||
| Restricted Equity | |||
| Share capital | 23 539 | 23 539 | 23 539 |
| Statutory reserve | 1 445 | 1 445 | 1 445 |
| Reserve for development expenses | 14 436 | 16 885 | 15 911 |
| Total restricted equity | 39 420 | 41 868 | 40 895 |
| Unrestricted Equity | |||
| Share premium reserve | 168 316 | 168 316 | 168 316 |
| Retained earnings | -68 741 | -60 916 | -59 942 |
| Profit/loss for the year | -13 917 | -8 468 | -10 274 |
| Total non-restricted equity | 85 657 | 98 933 | 98 100 |
| 125 078 | 140 801 | 138 995 | |
| Total Equity | |||
| LONG-TERM DEBT | |||
| Long term debt | 5 386 | 11 317 | 5 337 |
| TOTAL LONG-TERM DEBT | 5 386 | 11 317 | 5 337 |
| SHORT-TERM LIABILITIES | |||
| Short-term liabilities | 24 890 | 22 864 | 28 979 |
| Total Short-term liabilities | 24 890 | 22 864 | 28 979 |
| TOTAL EQUITY AND LIABILITIES | 155 355 | 174 982 | 173 312 |
{24}------------------------------------------------
| 2025 | 2024 | 2025 | 2024 | 2024 | Rolling | |
|---|---|---|---|---|---|---|
| Amounts in SEK thousands unless otherw ise stated | Jul-Sep | Jul-Sep | Jan-Sep | Jan-Sep | Full-year | 12 mth |
| Net sales | 20 006 | 22 799 | 60 797 | 65 065 | 86 852 | 82 584 |
| Net sales grow th, % | -12,3% | 28,7% | -6,6% | 18,8% | 15,7% | -3,3% |
| Gross margin, % | 75,8% | 74,3% | 73,8% | 72,7% | 72,6% | 73,4% |
| EBITDA | 4 351 | 6 785 | 2 115 | 9 943 | 13 379 | 5 552 |
| Operating profit/loss | -641 | 1 150 | -13 399 | -7 340 | -9 414 | -15 473 |
| Working capital * | 28 314 | 43 386 | 28 314 | 43 386 | 38 019 | 28 314 |
| Capital employed | 148 768 | 169 606 | 148 768 | 169 606 | 162 455 | 148 768 |
| Liquidity ratio, % | 176,6% | 234,7% | 176,6% | 234,7% | 189,3% | 176,6% |
| Equity/assets ratio, % | 74,6% | 75,8% | 74,6% | 75,8% | 74,4% | 74,6% |
| Earnings per share before dilution, SEK | -0,01 | 0,02 | -0,17 | -0,09 | -0,11 | -0,19 |
| Earnings per share after dilution, SEK | -0,01 | 0,02 | -0,17 | -0,09 | -0,11 | -0,19 |
| Equity per share, SEK | 1,75 | 1,94 | 1,75 | 1,94 | 1,93 | 1,75 |
| Number of shares (thousands) | 78 464 | 78 464 | 78 464 | 78 464 | 78 464 | 78 464 |
| Weighted avg. number of shares, adjusted for dilution | ||||||
| effect (thousands) | 78 464 | 78 464 | 78 464 | 78 464 | 78 464 | 78 464 |
| Number of employees at the end of the period | 37 | 30 | 37 | 30 | 35 | 37 |
| Average number of employees during the period | 36 | 30 | 36 | 31 | 32 | 35 |
| Annual Recurring Revenue | 18 412 | 18 434 | 18 412 | 18 434 | 18 980 |
* The key indicator is calculated excluding current liabilities to EastCoast International AB.
{25}------------------------------------------------
| Amounts in SEK thousands | 2025 | 2024 | 2025 | 2024 | 2024 | Rolling |
|---|---|---|---|---|---|---|
| unless otherw ise stated | Jul-Sep | Jul-Sep | Jan-Sep | Jan-Sep | Full-year | 12 mth |
| Net sales | 20 006 | 22 799 | 60 797 | 65 065 | 86 852 | 82 584 |
| Net sales grow th, % | -12,3% | 28,7% | -6,6% | 18,8% | 15,7% | -3,3% |
| Gross profit | 15 168 | 16 936 | 44 839 | 47 294 | 63 066 | 60 611 |
| Net sales | 20 006 | 22 799 | 60 797 | 65 065 | 86 852 | 82 584 |
| Gross margin, % | 75,8% | 74,3% | 73,8% | 72,7% | 72,6% | 73,4% |
| Operating profit/loss | -641 | 1 150 | -13 399 | -7 340 | -9 414 | -15 473 |
| Net sales | 20 006 | 22 799 | 60 797 | 65 065 | 86 852 | 82 584 |
| Operating margin, % | -3,2% | 5,0% | -22,0% | -11,3% | -10,8% | -18,7% |
| EBITDA | 4 351 | 6 785 | 2 115 | 9 943 | 13 379 | 5 552 |
| Depreciation and amortization | -4 992 | -5 636 | -15 514 | -17 283 | -22 794 | -21 025 |
| Operating profit/loss | -641 | 1 150 | -13 399 | -7 340 | -9 414 | -15 473 |
| Current assets | 51 134 | 64 815 | 51 134 | 64 815 | 67 686 | 51 134 |
| Current liabilities excl. current liabilities EastCoast | ||||||
| International* | 22 820 | 21 429 | 22 820 | 21 429 | 29 667 | 22 820 |
| Working capital | 28 314 | 43 386 | 28 314 | 43 386 | 38 019 | 28 314 |
| Sales expenses | -6 855 | -6 705 | -24 761 | -24 588 | -32 982 | -33 155 |
| Administrative expenses | -2 881 | -2 495 | -10 711 | -10 089 | -13 789 | -14 411 |
| R&D expenses | -6 033 | -6 325 | -20 279 | -20 219 | -26 966 | -27 026 |
| Other operating income/expenses | -40 | -260 | -2 487 | 263 | 1 256 | -1 494 |
| Total operating expenses | -15 809 | -15 786 | -58 238 | -54 634 | -72 480 | -76 086 |
| Cost of goods and services sold | -4 838 | -5 863 | -15 958 | -17 771 | -23 786 | -21 973 |
| Depreciation Cost of goods sold | 3 896 | 4 498 | 12 283 | 13 843 | 18 230 | 16 670 |
| Cost of goods and services sold excluding depreciation |
-942 | -1 365 | -3 675 | -3 928 | -5 556 | -5 302 |
| Operating expenses | -15 809 | -15 786 | -58 238 | -54 634 | -72 480 | -76 086 |
| Depreciation Operating expenses | 1 096 | 1 137 | 3 231 | 3 441 | 4 564 | 4 354 |
| Operating costs excluding depreciation | -14 713 | -14 649 | -55 007 | -51 193 | -67 916 | -71 730 |
| Balance sheet total | 184 209 | 200 868 | 184 209 | 200 868 | 203 066 | 184 209 |
| Non-interest-bearing liabilities | 35 441 | 31 262 | 35 441 | 31 262 | 40 611 | 35 441 |
| Capital employed | 148 768 | 169 606 | 148 768 | 169 606 | 162 455 | 148 768 |
| Closing equity | 137 395 | 152 200 | 137 395 | 152 200 | 151 163 | 137 395 |
| Average equity | 142 565 | 154 739 | 142 565 | 154 739 | 152 700 | 142 565 |
| Current assets minus inventories Current liabilities |
50 884 28 807 |
64 584 27 518 |
50 884 28 807 |
64 584 27 518 |
67 445 35 621 |
50 884 28 807 |
| 177% | 235% | 177% | 235% | 189% | 177% | |
| Liquidity ratio, % | ||||||
| Equity | 137 395 | 152 200 | 137 395 | 152 200 | 151 163 | 137 395 |
| Total assets | 184 209 | 200 868 | 184 209 | 200 868 | 203 066 | 184 209 |
| Equity/assets ratio, % | 74,6% | 75,8% | 74,6% | 75,8% | 74,4% | 74,6% |
{26}------------------------------------------------
| 2025 | 2024 | 2025 | 2024 | 2024 | Rolling | ||
|---|---|---|---|---|---|---|---|
| Amounts in SEK thousand | Note | Jul-Sep | Jul-Sep | Jan-Sep | Jan-Sep | Full-year | 12 mth |
| Net sales | 2,3 | 20 006 | 22 799 | 60 797 | 65 065 | 86 852 | 82 584 |
| Cost of goods and services sold excluding depreciation | -942 | -1 365 | -3 674 | -3 928 | -5 556 | -5 302 | |
| Operating costs excluding depreciation | -17 748 | -17 127 | -63 764 | -59 250 | -78 883 | -83 398 | |
| Capitalized development expenses | 3 035 | 2 478 | 8 756 | 8 056 | 10 967 | 11 668 | |
| EBITDA | 4 351 | 6 785 | 2 115 | 9 943 | 13 379 | 5 552 | |
| Total depreciation excluding acquired immaterial assets | -4 385 | -5 025 | -13 701 | -15 463 | -20 362 | -18 601 | |
| Total depreciation acquired immaterial assets | -607 | -610 | -1 813 | -1 820 | -2 431 | -2 424 | |
| Operating profit/loss | -641 | 1 150 | -13 399 | -7 340 | -9 414 | -15 473 |
{27}------------------------------------------------
ARR is defined as repeat revenues at the end of the quarter for Digital Identity, converted to a 12-month period. Consequently, there is no direct link between the ARR figure and future software revenues for Digital Identity. The ARR metric is used for contractual recurring revenues for the Digital Identity segment, as Digital Identity has a large customer base based on SaaS revenues. There are a small number of large customers in Biometric Technologies, and therefore license fees are not followed up using the definition of ARR in this segment.
Gross profit/loss divided by net sales. Indicates the proportion of sales that is left over to cover wages, other operating expenses, interest and profit.
Profit/loss before financial items and depreciation. This key indicator shows the Group's profit/loss before depreciation/amortization of capitalized assets. This measure makes it possible to make comparisons with other companies, regardless of whether the operation is based on acquisitions or through organic growth.
Equity at the end of the period. Equity is the difference between the Group's assets and liabilities, which corresponds to the Group's equity that has been contributed by shareholders and the Group's accumulated profit.
Equity on the balance sheet date divided by the number of shares on the balance sheet date. A measure of the value of equity per share, which is used when valuing the share in relation to the share price.
The average equity was calculated as equity for the last four quarters divided by four.
Cash flow from operating activities after changes in working capital. The operating cash flow indicates whether a company can generate a sufficiently positive cash flow to maintain and expand its operation, or whether it needs external financing.
Current assets excluding inventories divided by current liabilities. This key figure shows the group's ability to pay in the short term.
Percentage change compared with the corresponding period in the previous year. A measure of whether a company's net sales are increasing.
{28}------------------------------------------------
Profit/loss for the period divided by weighted average number of shares.
Profit/loss for the period divided by average number of shares.
Profit/loss after tax divided by average equity. This key indicator shows the business's return on shareholders' capital invested and is thus a measure of how profitable the Group is. Investors can compare this measure with the current bank interest rate or return from alternative investments. The measure can also be used to compare profitability between companies in the same industry.
Current assets less current liabilities. This measure shows the capital a company needs to finance operating activities.
Operating expenses excluding cost of goods sold. Operating expenses are expenses that do not belong directly to a particular product or product group. Common operating expenses include, for example, wages and other personnel expenses, as well as rental of premises.
Operating profit/loss divided by net sales. Defines what proportion of each Swedish krona of sales is left over to cover interest, taxes and any possible profit.
Profit/loss before net financial items and tax. A measure of a company's profit before interest and taxes, i.e., the difference between operating income and operating expenses.
Equity divided by assets on the balance sheet date. This key indicator shows what proportion of assets is funded by equity. This measure can be of interest when assessing the Group's ability to pay in the long term.
Total assets less non-interest-bearing liabilities and provisions. This measure shows how much capital is used in operations and is thus one component of measuring the return from operations.
{29}------------------------------------------------
precisebiometrics.com

Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.